GeneDx Holdings Corp.
WGS
$56.33
$4.538.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 431.93M | 416.39M | 393.30M | 357.20M | 326.81M |
| Total Other Revenue | 10.75M | 11.15M | 8.89M | 5.13M | 3.33M |
| Total Revenue | 442.68M | 427.54M | 402.19M | 362.32M | 330.14M |
| Cost of Revenue | 134.77M | 129.36M | 122.08M | 118.90M | 114.68M |
| Gross Profit | 307.91M | 298.18M | 280.11M | 243.42M | 215.47M |
| SG&A Expenses | 261.97M | 237.82M | 211.07M | 187.07M | 182.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 475.98M | 439.21M | 392.23M | 356.88M | 344.24M |
| Operating Income | -33.31M | -11.67M | 9.96M | 5.44M | -14.10M |
| Income Before Tax | -77.47M | -21.14M | 2.51M | 1.54M | -38.39M |
| Income Tax Expenses | 334.00K | -116.00K | 424.00K | 130.00K | 186.00K |
| Earnings from Continuing Operations | -77.81 | -21.02 | 2.08 | 1.41 | -38.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -77.81M | -21.02M | 2.08M | 1.41M | -38.58M |
| EBIT | -33.31M | -11.67M | 9.96M | 5.44M | -14.10M |
| EBITDA | -7.85M | 12.65M | 32.97M | 27.90M | 7.39M |
| EPS Basic | -2.65 | -0.73 | 0.08 | 0.04 | -1.44 |
| Normalized Basic EPS | -0.72 | -0.33 | 0.42 | 0.33 | -0.61 |
| EPS Diluted | -2.67 | -0.75 | 0.06 | 0.02 | -1.44 |
| Normalized Diluted EPS | -0.73 | -0.34 | 0.41 | 0.32 | -0.61 |
| Average Basic Shares Outstanding | 115.76M | 114.58M | 113.31M | 111.61M | 109.65M |
| Average Diluted Shares Outstanding | 116.94M | 115.75M | 114.48M | 112.78M | 109.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |